A combination of elevated IL-6, TNF-α, and CRP provided preferable prediction performance in terms of AUC (0.83) over individual biomarkers, with considerable sensitivity (78.5%) and specificity (77.9%) for depression, but it demanded higher costs and additional time. Here, CRP is linked to depressive symptom measurement.